SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-17-011241
Filing Date
2017-10-04
Accepted
2017-10-04 15:57:16
Documents
6
Period of Report
2017-09-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 40806
2 ex1-1.htm EX-1.1 353154
3 ex3-1.htm EX-3.1 122314
4 ex4-1.htm EX-4.1 237761
5 ex99-1.htm EX-99.1 11471
6 ex99-2.htm EX-99.2 12040
  Complete submission text file 0001493152-17-011241.txt   778795
Mailing Address 1880 CENTURY PARK EAST, SUITE 1000 LOS ANGELES CA 90067
Business Address 1880 CENTURY PARK EAST, SUITE 1000 LOS ANGELES CA 90067 310-203-1000
RITTER PHARMACEUTICALS INC (Filer) CIK: 0001460702 (see all company filings)

IRS No.: 263474527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37428 | Film No.: 171121583
SIC: 2834 Pharmaceutical Preparations